Physician profile
Scott E Torness
NPI 1679599633
$5,453.23
in general payments reported to CMS, 2019-2025
18 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,370 · 2020: $348 · 2021: $233 · 2022: $1,462 · 2023: $300 · 2024: $1,497 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084 · Travel and Lodging: $841 · Long Term Medical Supply Or Device Loan: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.91 |
| Travel and Lodging | $841.23 |
| Long Term Medical Supply Or Device Loan | $115.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,826.62 | 2019-2025 | Hammertube Sterile Implant Kits, Portfolio, Phantom Metatarsal Shortening |
| Conetic Solutions, INC. | $1,221.43 | 2022 | |
| Gemini Medical LLC | $1,206.45 | 2019-2022 | |
| Smith+Nephew, INC. | $462.87 | 2019-2024 | Grafix Pl, Oasis, Grafix |
| Integra Lifesciences Corporation | $275.49 | 2019-2025 | Integra, Acell, Primatrix |
| Trilliant Surgical LLC. | $97.28 | 2020 | |
| Solventum Corporation | $70.14 | 2024-2025 | Prevena, 3m Cavilon, V.A.C. Veraflo Cleanse Choice |
| Depuy Synthes Sales INC. | $59.75 | 2019 | |
| Stryker Corporation | $54.76 | 2022-2023 | Aequalis Perform |
| Organogenesis INC. | $30.12 | 2023 | Puraply |
| Hartmann USA, INC. | $28.56 | 2023 | Zetuvit Plus |
| Kerecis Limited | $24.61 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Polynovo North America LLC | $23.86 | 2025 | Novosorb Btm |
| Averitas Pharma INC. | $15.68 | 2024 | Qutenza |
| Zimmer Biomet Holdings, INC. | $14.69 | 2023 | Medline Industries, INC., Tapestry, Accufill |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $14.08 | 2023 | Cimzia |
| Tei Medical INC. | $13.84 | 2019 | |
| Osiris Therapeutics INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Torness listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.